• 316 Citations
  • 9 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Larry D Anderson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 316 Citations
  • 9 h-Index
  • 15 Article
  • 1 Editorial
  • 1 Letter

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

Richardson, P. G., Bensinger, W. I., Huff, C. A., Costello, C. L., Lendvai, N., Berdeja, J. G., Anderson, L. D., Siegel, D. S., Lebovic, D., Jagannath, S., Laubach, J. P., Stockerl-Goldstein, K. E., Kwei, L., Clow, F., Elias, L., Salman, Z., Graef, T., Bilotti, E. & Vij, R., Mar 1 2018, In : British Journal of Haematology. 180, 6, p. 821-830 10 p.

Research output: Contribution to journalArticle

  • 4 Scopus citations

    Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory waldenström macroglobulinemia: Evidence for a graft-versus-lymphoma effect

    Maffini, E., Anderson, L. D., Sandmaier, B. M., Green, D. J., Storer, B. E., Niederwieser, D., Maziarz, R. T., Maloney, D. G. & Storb, R., Jun 3 2018, In : Haematologica. 103, 6, p. e252-e255

    Research output: Contribution to journalLetter

    Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

    Chari, A., Larson, S., Holkova, B., Cornell, R. F., Gasparetto, C., Karanes, C., Matous, J. V., Niesvizky, R., Valent, J., Lunning, M., Usmani, S. Z., Anderson, L. D., Chang, L., Lee, Y., Pak, Y., Salman, Z., Graef, T., Bilotti, E. & Chhabra, S., Apr 5 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

    Research output: Contribution to journalArticle

  • 9 Scopus citations

    Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

    Trudel, S., Lendvai, N., Popat, R., Voorhees, P. M., Reeves, B., Libby, E. N., Richardson, P. G., Anderson, L. D., Sutherland, H. J., Yong, K., Hoos, A., Gorczyca, M. M., Lahiri, S., He, Z., Austin, D. J., Opalinska, J. B. & Cohen, A. D., Dec 1 2018, In : The Lancet Oncology. 19, 12, p. 1641-1653 13 p.

    Research output: Contribution to journalArticle

  • 27 Scopus citations
    2 Scopus citations